6Sohail MR, Uslan DZ, Khan AH. Management and outcome of permanent pacemarker and implantable cardioverter- defibrillator infections [J]. J Am Coil Cardiol, 2007, 49.. 1851-1859.
7Nery PB, Fernandes R, Nair GM, et al. Device related infection among patients with pacemakers and implantable defibrillation: incidence, risk factors, and consequences [J]. J Cardiovasc Electrophysiol, 2010, 21:786-790.
8Catanchin A, Murdock CJ, Athan E. Pacemaker infection: a 10 year experience [J]. Heart Lung Cire, 2007, 16: 434-439.
9Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association [J]. Europace, 2010, 12: 1526-1536.
10Bongiorni MG, Marinskis G, Lip GY, et al. How European centres diagnose, treat and prevent CIED infections., results of an European Heart Rhythm Association survey [J]. European, 2012, 14: 1666- 1669.
